{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:23Z","timestamp":1792788263565,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases \u2010 National Science and Technology Major Project","award":["No. 2023ZD0504100"],"award-info":[{"award-number":["No. 2023ZD0504100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-026-01286-x","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:43:32Z","timestamp":1773236612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The remnant cholesterol inflammatory index and risk of future cardiovascular disease in early CKM syndrome: findings from CHARLS"],"prefix":"10.1186","volume":"45","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemiao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanshuai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"6","key":"1286_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.26599\/1671-5411.2023.06.006","volume":"20","author":"ZW Wang","year":"2023","unstructured":"Wang ZW. Status of cardiovascular disease in China. J Geriatr Cardiol. 2023;20(6):397\u20138.","journal-title":"J Geriatr Cardiol"},{"key":"1286_CR2","doi-asserted-by":"crossref","unstructured":"Zheng C, Wang X, Gu R, Wang W, Tian Y, Pei X, Jia Q, Song Q, Cao X, Tian Y et al. The Burden of Cardiovascular Disease in China. Jacc 2025.","DOI":"10.1016\/j.jacc.2025.08.060"},{"issue":"20","key":"1286_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"4","key":"1286_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dbi19-0007","volume":"69","author":"A Chait","year":"2020","unstructured":"Chait A, Ginsberg HN, Vaisar T, Heinecke JW, Goldberg IJ, Bornfeldt KE. Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease. Diabetes. 2020;69(4):508\u201316.","journal-title":"Diabetes"},{"key":"1286_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01984-4","author":"W Wu","year":"2023","unstructured":"Wu W, Chen G, Wu K, Zheng H, Chen Y, Wang X, et al. Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study. Cardiovasc Diabetol. 2023. https:\/\/doi.org\/10.1186\/s12933-023-01984-4.","journal-title":"Cardiovasc Diabetol"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annepidem.2024.05.005","volume":"94","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang Y, Wang X, Chen S, Tian X, Xu Q, Xia X, Wu S, Liu F, Wang A. Cumulative remnant cholesterol burden increases the risk of cardiovascular disease among young adults. Ann Epidemiol. 2024;94:127\u201336.","journal-title":"Ann Epidemiol"},{"key":"1286_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2023.03.012","volume":"371","author":"XH Yang","year":"2023","unstructured":"Yang XH, Zhang BL, Cheng Y, Fu SK, Jin HM. Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: a systemic review and meta-analysis. Atherosclerosis. 2023;371:21\u201331.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1286_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","volume":"62","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Kamstrup PR, Bang LE, Varbo A, Langsted A, Jepsen A-M. Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease. Clin Chem. 2016;62(4):593\u2013604.","journal-title":"Clin Chem"},{"key":"1286_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002765","author":"PH Joshi","year":"2016","unstructured":"Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, et al. Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson Heart and Framingham Offspring Cohort Studies. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.115.002765.","journal-title":"J Am Heart Assoc"},{"issue":"42","key":"1286_CR10","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42(42):4324\u201332.","journal-title":"Eur Heart J"},{"key":"1286_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.2561","author":"D Delialis","year":"2021","unstructured":"Delialis D, Aivalioti E, Mavraganis G, Dimopoulou AM, Sianis A, Angelidakis L, et al. Remnant cholesterol is an independent determinant of the presence and extent of subclinical carotid atherosclerosis in statin-naive individuals. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehab724.2561.","journal-title":"Eur Heart J"},{"key":"1286_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hjc.2024.05.002","volume":"85","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu S, Tian X, Xu Q, Xia X, Zhang X, Li J, Chen S, Liu F, Wang A. Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts cardiovascular disease: the Kailuan prospective cohort study. Hellenic J Cardiol. 2025;85:48\u201357.","journal-title":"Hellenic J Cardiol"},{"key":"1286_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1231","author":"K Grzelakowska","year":"2023","unstructured":"Grzelakowska K, Vine D, Proctor S, Raggi P, Kubica J, Navarese EP. Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a Mendelian randomization study. Eur Heart J. 2023. https:\/\/doi.org\/10.1093\/eurheartj\/ehad655.1231.","journal-title":"Eur Heart J"},{"key":"1286_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02733-w","author":"Z Wu","year":"2023","unstructured":"Wu Z, Wang J, Zhang H, Pan H, Li Z, Liu Y, et al. Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol. BMC Med. 2023. https:\/\/doi.org\/10.1186\/s12916-023-02733-w.","journal-title":"BMC Med"},{"key":"1286_CR15","doi-asserted-by":"publisher","DOI":"10.31083\/RCM25985","author":"N-Q Wu","year":"2025","unstructured":"Wu N-Q, Li Z-F, Li X. Remnant cholesterol and residual risk of atherosclerotic cardiovascular disease. Rev Cardiovasc Med. 2025. https:\/\/doi.org\/10.31083\/RCM25985.","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"1286_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","volume":"40","author":"PB Sandesara","year":"2019","unstructured":"Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537\u201357.","journal-title":"Endocr Rev"},{"key":"1286_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054268","author":"F Baratta","year":"2023","unstructured":"Baratta F, Cocomello N, Coronati M, Ferro D, Pastori D, Angelico F, et al. Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054268.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1286_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","volume":"82","author":"PM Burger","year":"2023","unstructured":"Burger PM, Koudstaal S, Mosterd A, Fiolet ATL, Teraa M, van der Meer MG, Cramer MJ, Visseren FLJ, Ridker PM, Dorresteijn JAN, et al. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease. J Am Coll Cardiol. 2023;82(5):414\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"9709","key":"1286_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"C Emerging Risk Factors","year":"2010","unstructured":"Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132\u201340.","journal-title":"Lancet"},{"issue":"10","key":"1286_CR20","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jacasi.2025.06.021","volume":"5","author":"X Kong","year":"2025","unstructured":"Kong X, Du L, Liu W, Qiao Y, Ma C. The prognostic value of hsCRP in CVD\/CKD among East Asian population. JACC Asia. 2025;5(10):1302\u201312.","journal-title":"JACC Asia"},{"key":"1286_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","volume":"76","author":"J Chen","year":"2025","unstructured":"Chen J, Wu Q, Liu H, Hu W, Zhu J, Ji Z, et al. Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China health and retirement longitudinal study. J Adv Res. 2025;76:543\u201352.","journal-title":"J Adv Res"},{"key":"1286_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000046052","author":"X Chen","year":"2025","unstructured":"Chen X, Chen J, Gong H, Fan Y, Luo Y. Association of remnant cholesterol inflammation index as potential marker of metabolic syndrome: a cross-sectional study from NHANES and CHARLS. Medicine. 2025. https:\/\/doi.org\/10.1097\/MD.0000000000046052.","journal-title":"Medicine"},{"key":"1286_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02580-z","author":"Y Wang","year":"2025","unstructured":"Wang Y, Bi L, Li Q, Wang Q, Lv T, Zhang P. Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys. Lipids Health Dis. 2025. https:\/\/doi.org\/10.1186\/s12944-025-02580-z.","journal-title":"Lipids Health Dis"},{"key":"1286_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02650-2","author":"Y Yu","year":"2025","unstructured":"Yu Y, Zhang Y, Zhu C, Duan T, Rao Z. Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale. Lipids Health Dis. 2025. https:\/\/doi.org\/10.1186\/s12944-025-02650-2.","journal-title":"Lipids Health Dis"},{"key":"1286_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112989","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Wang T, Peng W, Ning M, Liu Y. Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in Cardiovascular-Kidney-Metabolic syndrome. Diabetes Res Clin Pract. 2025. https:\/\/doi.org\/10.1016\/j.diabres.2025.112989.","journal-title":"Diabetes Res Clin Pract"},{"key":"1286_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/jdr\/1579313","author":"N Chen","year":"2025","unstructured":"Chen N, Gong A, Huang X, Wang N, Pan T, Pan X, et al. Remnant cholesterol inflammatory index and new-onset diabetes in middle\u2010aged and older adults: evidence from prospective surveys of Chinese and UK populations. J Diabetes Res. 2025. https:\/\/doi.org\/10.1155\/jdr\/1579313.","journal-title":"J Diabetes Res"},{"key":"1286_CR27","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.2147\/RMHP.S566696","volume":"18","author":"C Luo","year":"2025","unstructured":"Luo C, Du J, Zhang C. Remnant cholesterol inflammatory index for predicting heart failure risk in patients with coronary artery disease and type 2 diabetes: a retrospective study using multiple machine learning approaches. Risk Manag Healthc Policy. 2025;18:4027\u201336.","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"1286_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"key":"1286_CR29","doi-asserted-by":"crossref","unstructured":"Cui C, Liu L, zhang T, Fang L, Mo Z, Qi Y, Zheng J, Wang Z, Xu H, Yan H et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol 2023, 22(1).","DOI":"10.1186\/s12933-023-02055-4"},{"key":"1286_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02352-6","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024. https:\/\/doi.org\/10.1186\/s12933-024-02352-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1286_CR31","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"Y-C Ma","year":"2006","unstructured":"Ma Y-C, Zuo L, Chen J-H, Luo Q, Yu X-Q, Li Y, Xu J-S, Huang S-M, Wang L-N, Huang W, et al. Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease. J Am Soc Nephrol. 2006;17(10):2937\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"4S","key":"1286_CR32","first-page":"S117","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease. Improving Global Outcomes CKDWG: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"24","key":"1286_CR33","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, Palaniappan LP, Sperling LS, Virani SS, Ho JE, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023;148(24):1982\u20132004.","journal-title":"Circulation"},{"issue":"6","key":"1286_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, et al. Development and Validation of the American Heart Association\u2019s PREVENT Equations. Circulation. 2024;149(6):430\u201349.","journal-title":"Circulation"},{"key":"1286_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6892","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"issue":"1","key":"1286_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Circulation. 2003;107(1):139\u201346.","journal-title":"Circulation"},{"issue":"3","key":"1286_CR37","first-page":"243","volume":"3","author":"A Moran","year":"2010","unstructured":"Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen C-S, Liu J, Cheng J, Bibbins-Domingo K, Shen Y-M, et al. Future Cardiovascular Disease in China. Circulation: Cardiovasc Qual Outcomes. 2010;3(3):243\u201352.","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"key":"1286_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118585","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality. Atherosclerosis. 2024. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118585.","journal-title":"Atherosclerosis"},{"issue":"12","key":"1286_CR39","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","volume":"480","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yang S, Tan Y, Zhang Q, Wang H, Tao J, Liu Q, Wang Q, Feng W, Li Z, et al. Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms\u2013a comprehensive review. Mol Cell Biochem. 2025;480(12):6039\u201375.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"1286_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/advances\/nmaa105","volume":"12","author":"Y Kim","year":"2021","unstructured":"Kim Y, Kim O-K. Potential roles of adipocyte extracellular vesicle\u2013derived miRNAs in obesity-mediated insulin resistance. Adv Nutr. 2021;12(2):566\u201374.","journal-title":"Adv Nutr"},{"key":"1286_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051305","author":"I Kojta","year":"2020","unstructured":"Kojta I, Chaci\u0144ska M, B\u0142achnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12051305.","journal-title":"Nutrients"},{"issue":"11","key":"1286_CR42","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"issue":"7","key":"1286_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951\u201368.","journal-title":"Circ Res"},{"issue":"5","key":"1286_CR44","first-page":"671","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. Can J Cardiol. 2020;36(5):671\u201382.","journal-title":"Can J Cardiol"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-026-01286-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:26:13Z","timestamp":1776666373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-026-01286-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1186\/s41043-026-01286-x","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this study were derived from the China Health and Retirement Longitudinal Study (CHARLS). All participants in CHARLS provided written informed consent prior to data collection. Ethical approval for the CHARLS project was obtained from the Biomedical Ethics Committee of Peking University (IRB00001052-11015). All procedures in the present study complied with the Declaration of Helsinki and relevant regulatory guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}